Establishment Labs/$ESTA
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Establishment Labs
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Ticker
$ESTA
Sector
Primary listing
Employees
1,018
Headquarters
Alajuela, Costa Rica
Website
ESTA Metrics
BasicAdvanced
$1.8B
-
-$2.82
1.06
-
Price and volume
Market cap
$1.8B
Beta
1.06
52-week high
$69.00
52-week low
$26.56
Average daily volume
541K
Financial strength
Current ratio
3.329
Quick ratio
1.974
Long term debt to equity
1,524.415
Total debt to equity
1,524.415
Interest coverage (TTM)
-2.24%
Profitability
EBITDA (TTM)
-44.529
Gross margin (TTM)
68.74%
Net profit margin (TTM)
-43.45%
Operating margin (TTM)
-28.14%
Effective tax rate (TTM)
-1.14%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
-10.81%
Return on equity (TTM)
-338.19%
Valuation
Price to revenue (TTM)
9.733
Price to book
114.39
Price to tangible book (TTM)
393.65
Growth
Revenue change (TTM)
24.76%
Earnings per share change (TTM)
9.60%
3-year revenue growth (CAGR)
7.62%
3-year earnings per share growth (CAGR)
-3.23%
What the Analysts think about ESTA
Analyst ratings (Buy, Hold, Sell) for Establishment Labs stock.
Bulls say / Bears say
Q3 revenue jumped 33.8% year-over-year to $53.78 million, beating the analyst consensus of $52.50 million (Reuters)
Adjusted EBITDA turned positive at $1.2 million in Q3, the company's first positive quarter on that metric—a significant step toward overall profitability (Reuters)
Management raised the full-year 2025 revenue outlook to over $210 million, showing confidence in continued Motiva sales growth (Reuters)
Q2 operating loss widened to $14.11 million versus the expected $10.60 million, indicating ongoing cash outflows despite revenue growth (Reuters)
Net loss for Q2 increased to $16.59 million (EPS –$0.57), missing the consensus forecast of –$0.53, highlighting ongoing unprofitability (Reuters)
SG&A expenses jumped due to investments in the U.S. market, raising operating costs by more than $11 million year-over-year and putting pressure on margins (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 11 Nov 2025.
ESTA Financial Performance
Revenues and expenses
ESTA Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Establishment Labs stock?
Establishment Labs (ESTA) has a market cap of $1.8B as of November 14, 2025.
What is the P/E ratio for Establishment Labs stock?
The price to earnings (P/E) ratio for Establishment Labs (ESTA) stock is 0 as of November 14, 2025.
Does Establishment Labs stock pay dividends?
No, Establishment Labs (ESTA) stock does not pay dividends to its shareholders as of November 14, 2025.
When is the next Establishment Labs dividend payment date?
Establishment Labs (ESTA) stock does not pay dividends to its shareholders.
What is the beta indicator for Establishment Labs?
Establishment Labs (ESTA) has a beta rating of 1.06. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.